EquityZen Growth Technology Fund II LLC - Series 11
Raised
$6M
Investors
20
Min Invest
$150,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund II LLC - Series 11 is a Delaware-organized pooled investment fund that raised $5.7M from 20 investors under Rule 506(b) and Section 3(c) exemptions, with a $150K minimum investment. Filed December 29, 2025 by EquityZen Advisors LLC and Phil Haslett, this is part of the EquityZen platform, which operates approximately 150 related fund series entities focused on private equity investments.
This private equity fund vehicle uses the standard 506(b) exemption common to institutional and high-net-worth offerings, with a $150K minimum that positions it in the accredited-investor tier. The per-investor average of $285K and fund structure are consistent with series-level SPV offerings typical of secondary marketplace platforms targeting growth-stage technology companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
